单反酶融合的临床相关性和药用性:一项大规模研究
Jiao Feng1,2, Tonghui Ma3,4, Chunyang Wang3,4
1General Surgery, Cancer Center, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Zhejiang, China.
Cancer medicine
|September 10, 2024
概括
在晚期癌症中罕见的单个相互融合,可以通过一种新的算法检测和潜在地用激酶抑制剂 (KIs) 治疗. 这扩大了这些独特的基因组改变患者的治疗选择.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 之前的研究表明RNA替代拼接会影响酶融合药物可用性.
- 在之前的研究中,缺少DNA级别的激酶域的单个相互融合,显示了RNA级别的可药性.
研究的目的:
- 为了研究单独的相互融合的临床意义.
- 在大量患者队列中评估广泛的激酶融合谱.
主要方法:
- 1943名患者的多中心RNA测序.
- 对ALK,ROS1,RET,BRAF,NTRK,MET,NRG1和EGFR融合的临床随访和分析.
- 使用RNA下一代测序 (NGS) 和光现场混合 (FISH) 的验证.
主要成果:
- 鉴定了51例 (2.57%) 的单肢相互融合,主要是肺癌,结直肠癌和质瘤癌.
- 在ALK,ROS1,RET和BRAF融合中确认了功能性激酶域,与对激酶抑制剂 (KI) 的积极反应相关.
- 发现EGFR,NRG1和NTRK融合的非功能转录,表明需要替代疗法.
结论:
- 介绍了一种新的算法,用于检测和治疗晚期癌症中唯一的相互融合.
- 扩大了可能接受酶抑制剂治疗的患者群体.
相关概念视频
Transducer Mechanism: Enzyme-Linked Receptors
2.4K
Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Major types that are helpful drug targets include:
2.4K
Receptor Tyrosine Kinases
12.5K
Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
12.5K
MAPK Signaling Cascades
5.3K
Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
5.3K
Conservative Site-specific Recombination and Phase Variation
5.9K
Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
The recognition sites for Cre recombinase called LoxP...
5.9K
Enzyme-linked Receptors
77.6K
Enzyme-linked receptors are proteins that act as both receptor and enzyme, activating multiple intracellular signals. This is a large group of receptors that include the receptor tyrosine kinase (RTK) family. Many growth factors and hormones bind to and activate the RTKs.
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
Neurotrophin (NT) receptors are a family of RTKs, including trkA, trkB, and trkC (tropomyosin-related kinase) receptors. TrkA is specific for nerve growth factor (NGF), neurotrophin-6, and neurotrophin-7. TrkB binds...
77.6K


